# Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia

> **NCT01130662** · PHASE1 · COMPLETED · sponsor: **University of Kansas** · enrollment: 16 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** combination therapy using decitabine and midostaurin

## Key facts

- **NCT ID:** NCT01130662
- **Lead sponsor:** University of Kansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130662, "Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01130662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*